EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of

Status Completed

Clinical Trial Summary

Few clinical evidence for the Contour 3D Tricuspid Annuloplasty Ring exists; therefore, in order to position this product on the market, a post-market release study was completed. The purpose of this study was to evaluate the hemodynamic performance of the Contour 3D® Tricuspid Annuloplasty Ring following Tricuspid Valve (TV) repair in a post-market environment.

Clinical Trial Description

The EASE TRICUSPID Clinical Trial was a prospective, non-randomized, non-interventional, post-market release study. The purpose of this study was to evaluate the hemodynamic performance of the Contour 3D® Tricuspid Annuloplasty Ring following Tricuspid Valve (TV) repair in a post-market environment. Therefore, the primary objective of the EASE Tricuspid Study was to evaluate the hemodynamic performance of the Contour 3D® Tricuspid Annuloplasty Ring (Contour 3D ring) in subjects with tricuspid regurgitation who had a clinical indication for TV repair in a post-market use. Secondary objectives included the evaluation of the effect of TV repair with the Contour 3D ring on the right ventricular function, as well as the assessment of the effect of TV repair with the Contour 3D ring on the functional status in subjects undergoing TV repair in a post-market environment. Subjects eligible for TV repair and compliant with the enrollment criteria were considered by the Investigator for inclusion in the study. To minimize bias, enrolled subjects were followed by their own physician in accordance with the center's established practice for routine follow up. Follow-up sessions were planned at the physician's discretion. To meet the intended goals, appropriate clinical data were collected at baseline (pre-surgery), during the surgical procedure, at discharge and during the follow-up period at 6 months. Experienced echo-cardiologists evaluated the echos. At the time of enrollment it was not certain if the subject would receive a Contour 3D ring, since the surgeon might have decided during surgery that another treatment was more beneficial to the subject. In this case, the subject was terminated from the study. ;

Study Design

Related Conditions & MeSH terms

Tricuspid Valve Insufficiency

Clinical Trial Details

NCT number	NCT01532921
Study type	Observational
Source	Medtronic Cardiovascular
Contact
Status	Completed
Phase
Start date	January 2011
Completion date	January 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06196684` - Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
Not yet recruiting	`NCT03278418` - Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach	N/A
Terminated	`NCT03632967` - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System	N/A
Active, not recruiting	`NCT05724225` - "Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
Completed	`NCT02981953` - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System	N/A
Completed	`NCT01444222` - Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart
Recruiting	`NCT04653428` - German Registry for Transcatheter Tricuspid Valve Interventions
Recruiting	`NCT02574650` - Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.	N/A
Completed	`NCT04945005` - Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry
Recruiting	`NCT03225612` - Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)	N/A
Completed	`NCT01585779` - Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial	N/A
Withdrawn	`NCT03166488` - MRE Evaluation of Liver Stiffness After Tricuspid Valvular Repair	N/A
Completed	`NCT03604484` - Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery	N/A
Completed	`NCT01537458` - Long-term Outcome After Isolated Tricuspid Valve Repair
Recruiting	`NCT05913908` - EFS of the DUO System for Tricuspid Regurgitation (TANDEM II)	N/A
Recruiting	`NCT04436653` - THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve	N/A
Completed	`NCT01334801` - Biomarkers in Aortic Stenosis - B.A.S.S.
Recruiting	`NCT04735003` - Transcatheter Interventions for Tricuspid Insufficiency in Italy
Recruiting	`NCT02314897` - Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study	N/A
Active, not recruiting	`NCT04614402` - Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms